to Carbapenems and Fosfomycin, raising the issue of feasible, cheap, and safe treatment strategies in this vulnerable population vis a vis applicability and usefulness of empirical antimicrobial therapy. Conclusion:The difference in prevalence rates of UTI in pregnancy is attributed to variations in socio-economic status, education, demography, social practices, and environment.The high observed prevalence rate calls for routine screening in all three trimesters of pregnancy and most importantly in the first visit and rational antimicrobial therapy for UTI in pregnancy as part of standard obstetric care.
No takes yet. Share an insight, caveat, or question.
Basu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: